Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

3 years ago 284

Moderna shares plunged 12.3% successful premarket trading connected Thursday aft income of the company’s Covid-19 vaccine fell abbreviated of Wall Street analysts’ estimates by much than a cardinal dollars.

The institution reported full gross of $5 cardinal for the 3rd 4th of the year, 20% abbreviated of the FactSet expert statement estimation of $6.2 billion. Spikevax, Moderna‘s (ticker: MRNA) Covid-19 vaccine, is the company’s lone product.

The...

Read Entire Article

Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

Related

Henry Ford’s Great-Great Granddaughter Bought Up Ford Stock

Novavax stock volatile following positive early COVID-19 vac...

I’ll have $5 million for retirement when I sell my dental pr...

Apple iPhone Sales Are Stronger Than Expected, Says Morgan S...

Trending

Popular

Muḥammad ibn Mūsā al-Khwārizmī

Johnson and Johnson to Seek Authorization for a Booster Shot...

Irony: Matt Gaetz, Under Investigation for Exploitation of Y...

Cubans are risking everything to enter the US

How a conspiracy theory about the Amazon forest echoes in Bo...